4.8 Article

PAXT-1 Promotes XRN2 Activity by Stabilizing It through a Conserved Domain

Journal

MOLECULAR CELL
Volume 53, Issue 2, Pages 351-360

Publisher

CELL PRESS
DOI: 10.1016/j.molcel.2014.01.001

Keywords

-

Funding

  1. European Union Seventh Framework Programme (FP7) [241985]
  2. Novartis Research Foundation through the FMI
  3. Swiss National Science Foundation [SNF 31003A_127052, SNF 31003A_143313]
  4. Boehringer Ingelheim Fonds PhD Fellowship
  5. NIH Office of Research Infrastructure Programs [P40 OD010440]
  6. Swiss National Science Foundation (SNF) [31003A_127052, 31003A_143313] Funding Source: Swiss National Science Foundation (SNF)

Ask authors/readers for more resources

XRN2 is an essential eukaryotic exoribonuclease that processes and degrades various substrates. Here we identify the previously uncharacterized protein R05D11.6/PAXT-1 as a subunit of an XRN2 complex in C. elegans. Targeted paxt-1 inactivation through TALEN-mediated genome editing reduces XRN2 levels, decreases miRNA turnover activity, and results in worm death, which can be averted by over-expressing xrn-2. Hence, stabilization of XRN2 is a major function of PAXT-1. A truncated PAXT-1 protein retaining a predicted domain of unknown function (DUF3469) suffices to restore viability to paxt-1 mutant animals, elevates XRN2 levels, and binds to XRN2. This domain occurs in additional metazoan proteins and mediates interaction of human CDKN2AIP/CARF and NKRF/NRF with XRN2. Thus, we have identified a bona fide XRN2-binding domain (XTBD) that can link different proteins, and possibly functionalities, to XRN2.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available